Developed by Orphan Europe and approved by the EMEA, Pedea® (ibuprofen I.V.) is a ready to use intravenous formulation.
For more information please contact your local Orphan Europe office, or our international business department at request@orphan-europe.com.
View Pedea® European Summary of Product Characteristics (PDF)
|